Detecting the presence and progression of premalignant lung lesions via airway gene expression

Clinical Cancer Research

Volumn 23, Issue 17, 2017, Pages 5091-5100

  Beane, Jennifer ^a   Mazzilli, Sarah A ^a   Tassinari, Anna M ^a   Liu, Gang ^a   Zhang, Xiaohui ^a   Liu, Hanqiao ^a   Buncio, Anne Dy ^b   Dhillon, Samjot S ^c   Platero, Suso J ^d   Lenburg, Marc E ^a   Reid, Mary E ^c   Lam, Stephen ^b   Spira, Avrum E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TRANSCRIPTOME; TUMOR PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOENERGY; BRONCHIAL EPITHELIAL CELLL; BRONCHUS EPITHELIUM; BRONCHUS MUCOSA; CANCER GROWTH; CANCER PREVENTION; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA REPAIR; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC STABILITY; HF1A GENE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IL4 GENE; JAK GENE; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MATHEMATICAL ANALYSIS; NCAM1 GENE; OXIDATIVE PHOSPHORYLATION; PREMALIGNANT LESION; PRIORITY JOURNAL; RAC1 GENE; RESPIRATORY TRACT INFLAMMATION; RNA SEQUENCE; SCORING SYSTEM; SIGNAL TRANSDUCTION; SMOKING; SQUAMOUS CELL CARCINOMA; STAT GENE; TRANSCRIPTOMICS; UPREGULATION; AGED; BRONCHUS; CHEMICALLY INDUCED; CLASSIFICATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER;

ADULT; AGED; BRONCHI; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RNA, MESSENGER; SMOKERS; SMOKING; TRANSCRIPTOME;

EID: 85029485344     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-16-2540     Document Type: Article

References (56)

1. Beane J, Sebastiani P, Liu G, Brody JS, Lenburg ME, Spira A. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 2007; 8:R201.
2. Hackett NR, Heguy A, Harvey B-G, O'Connor TP, Luettich K, Flieder DB, et al. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 2003; 29: 331-43.
3. Spira A, Beane J, Shah V, Liu G, Schembri F, Yang X, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 2004; 101:10143-8.
4. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res 2011; 4:803-17.
5. Sridhar S, Schembri F, Zeskind J, Shah V, Gustafson AM, Steiling K, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 2008; 9:259.
6. Chari R, Lonergan KM, Ng RT, MacAulay C, Lam WL, Lam S. Effect ofactive smoking on the human bronchial epithelium transcriptome. BMC Genomics 2007; 8:297.
7. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007; 13:361-6.
8. Beane J, Sebastiani P, Whitfield TH, Steiling K, Dumas Y-M, Lenburg ME, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res 2008; 1:56-64.
9. Whitney DH, Elashoff MR, Porta-Smith K, Gower AC, Vachani A, Ferguson JS, et al. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med Genomics 2015; 8:18.
10. Silvestri GA, Vachani A, Whitney D, Elashoff M, Porta Smith K, Ferguson JS, et al. A bronchial genomic classifier for the diagnostic evaluation of lung cancer. N Engl J Med 2015; 373:243-51.
11. Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med 2010; 2:26ra25.
12. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006; 1:331-48.
13. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997; 89:1366-73.
14. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000; 60:1949-60.
15. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18: 643-50.
16. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002; 62:2370-7.
17. Lamy A, Sesboue R, Bourguignon J, Dautréaux B, Metayer J, Frébourg T, et al. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer 2002; 100:189-93.
18. Nakachi I, Rice JL, Coldren CD, Edwards MG, Stearman RS, Glidewell SC, et al. Application of SNP microarrays to the genome-wide analysis of chromosomal instability in premalignant airway lesions. Cancer Prev Res 2014; 7:255-65.
19. Rahman SMJ, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, et al. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res 2011; 71:3009-17.
20. Massion PP, Zou Y, Uner H, Kiatsimkul P, Wolf HJ, Baron AE, et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS One 2009; 4:e5611.
21. van Boerdonk RAA, Sutedja TG, Snijders PJF, Reinen E, Wilting SM, van de Wiel MA, et al. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer. Am J Respir Crit Care Med 2011; 184:948-56.
22. Ishizumi T, McWilliams A, MacAulay C, Gazdar A, Lam S. Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev 2010; 29:5-14.
23. Edell E, Lam S, Pass H, Miller YE, Sutedja T, Kennedy T, et al. Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial. J Thorac Oncol 2009; 4:49-54.
24. Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser W, et al. Persistence of bronchial dysplasia is associated with development of invasive squamous cell carcinoma. Cancer Prev Res 2016; 9:96-104.
25. van Boerdonk RAA, Smesseim I, Heideman DAM, Coupé VMH, Tio D, Grunberg K, et al. Close surveillance with long-term follow-up of subjects with preinvasive endobronchial lesions. Am J Respir Crit Care Med 2015; 192:1483-9.
26. Jeremy George P, Banerjee AK, Read CA, O'Sullivan C, Falzon M, Pezzella F, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007; 62:43-50.
27. Tammemagi MC, Lam SC, McWilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometryinlung cancer risk prediction. Cancer Prev Res 2011; 4:552-61.
28. Katz Y, Wang ET, Airoldi EM, Burge CB. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 2010; 7:1009-15.
29. Anders S, Pyl PT, Huber W. HTSeq-aPython framework towork with high-throughput sequencing data. Bioinformatics 2015; 31:166-9.
30. Piccolo SR, Sun Y, Campbell JD, Lenburg ME, Bild AH, Johnson WE. A single-sample microarray normalization method tofacilitate personalized-medicine workflows. Genomics 2012; 100:337-44.
31. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011; 12:323.
32. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25.
33. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43:e47.
34. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductorpackage for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26:139-40.
35. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012; 28:882-3.
36. Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014; 15:R29.
37. Wu D, Lim E, Vaillant F, AsselinLabat M-L, Visvader JE, Smyth GK. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 2010; 26:2176-82.
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50.
39. Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 2013; 14:7.
40. Dingley S, Chapman KA, Falk MJ. Fluorescence-activated cell sorting analysis of mitochondrial content, membrane potential, and matrix oxidant burden in human lymphoblastoid cell lines. Methods Mol Biol 2012; 837:231-9.
41. Mazzilli SA, Hershberger PA, Reid ME, Bogner PN, Atwood K, Trump DL, et al. Vitamin D repletion reduces the progression of premalignant squamous lesions in the NTCU lung squamous cell carcinoma mouse model. Cancer Prev Res 2015; 8:895-904.
42. Chacko BK, Kramer PA, Ravi S, Benavides GA, Mitchell T, Dranka BP, et al. The Bioenergetic Health Index: a new concept in mitochondrial translational research. Clin Sci 1979 2014; 127:367-73.
43. Ooi AT, Gower AC, Zhang KX, Vick JL, Hong L, Nagao B, et al. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis. Cancer Prev Res 2014; 7:487-95.
44. Dang CV Links between metabolism and cancer. Genes Dev 2012; 26:877-90.
45. Chen X, Qian Y, Wu S. The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med 2015; 79:253-63.
46. Wenz L-S, Opalinski Ł, Wiedemann N, Becker T. Cooperation of protein machineries in mitochondrial protein sorting. Biochim Biophys Acta 2015; 1853:1119-29.
47. Tan Z, Luo X, Xiao L, Tang M, Bode AM, Dong Z, et al. The role of PGC1a in cancer metabolism and its therapeutic implications. Mol Cancer Ther 2016; 15:774-82.
48. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1a mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 2014; 16:992-1003.
49. Fan W, Evans R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr Opin Cell Biol 2015; 33:49-54.
50. Phelan JJ, MacCarthy F, Feighery R, O'Farrell NJ, Lynam-Lennon N, Doyle B, et al. Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus. Cancer Lett 2014; 354: 122-31.
51. Xylas J, Varone A, Quinn KP, Pouli D, McLaughlin-Drubin ME, Thieu H-T, et al. Noninvasive assessment of mitochondrial organization in three-dimensional tissues reveals changes associated with cancer development. Int J Cancer 2015; 136:322-32.
52. Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, Teriete P, et al. Association of cancermetabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? J Transl Med 2014; 12:208.
53. Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, et al. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function. Cancer Prev Res 2014; 7:1149-59.
54. Zhang X, Sebastiani P, Liu G, Schembri F, Zhang X, Dumas YM, et al. Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium. Physiol Genomics 2010; 41: 1-8.
55. Campbell JD, Mazzilli SA, Reid ME, Dhillon SS, Platero S, Beane J, et al. The case for a precancer genome atlas (PCGA). Cancer Prev Res 2016; 9:119-24.
56. Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, et al. Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prev Res 2016; 9:2-10.